Initial experiences of switching to faricimab for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in an Asian population

PurposeTo describe the early experiences of patients with neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) whose treatment was switched to faricimab from other anti-vascular endothelial growth factor (VEGF) agents.MethodsThis is a prospective cohort of...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Farah N. I. Ibrahim, Kelvin Y. C. Teo, Tien-En Tan, Hiok Hong Chan, Priya R. Chandrasekaran, Shu-Yen Lee, Anna C. S. Tan, Ranjana Mathur, Choi Mun Chan, Shaun S. Sim, Gavin Siew Wei Tan, Ian Y. S. Yeo, Chui Ming Gemmy Cheung
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Frontiers Media S.A. 2024-01-01
سلاسل:	Frontiers in Ophthalmology
الموضوعات:	ANG-2 anti-vegf faricimab neovascular age-related macular degeneration polypoidal choroidal vasculopathy switch therapy
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fopht.2023.1346322/full
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!